Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
August 21, 2025Advanced ScienceOpen Access

Emerging cGAS‐STING Agonist‐Based Nanotherapeutics: Mechanistic Insights and Applications in Cancer Combination Therapy

View Full Paper
Ask AI
Bookmark
Share

Authors

ZWZ. L. WangYWYongjun WangZHZhonggui He

Discussion

Loading...

Member takes

Overview

Review highlights advancements in cGAS‐STING agonist nanotherapeutics for cancer, suggesting potential in combination therapies.

Key Points

  • Activation of the cGAS-STING pathway enhances antitumor immunity but faces drug delivery challenges, including stability and targeting.
  • Current advancements suggest that nanoparticulate systems can improve the delivery and efficacy of cGAS-STING agonists in cancer therapy.
  • Strategies combining cancer immunotherapy, chemotherapy, and other treatments demonstrate promising synergistic effects with cGAS-STING agonists.
  • Future research must address the remaining challenges of immunotoxicity and clinical application of STING agonist nanotherapeutics.

Cite This Study

Wang et al. (2025) studied this question.

synapsesocial.com/papers/68af76ad7567bf4f94fef206https://doi.org/10.1002/advs.202509890
View Full Paper
Ask AI
Bookmark
Share